Glaucoma, Open-Angle
Information
- Disease name
- Glaucoma, Open-Angle
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03868124 | Active, not recruiting | Phase 3 | Clinical Study Comparing Two Models of a Travoprost Intraocular Implant | September 17, 2018 | June 2024 |
| NCT05236439 | Active, not recruiting | N/A | Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma | May 1, 2022 | March 31, 2026 |
| NCT05159817 | Active, not recruiting | Study of an Interposition Supraciliary Implant in Patients With Open Angle Glaucoma | December 15, 2021 | December 31, 2024 | |
| NCT05127551 | Active, not recruiting | N/A | Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor | November 27, 2021 | February 28, 2025 |
| NCT03798223 | Active, not recruiting | N/A | Optimal Treatment Protocol for Selective Laser Trabeculoplasty | January 10, 2019 | May 31, 2025 |
| NCT05498103 | Active, not recruiting | Phase 4 | Use of Methazolamide to Lower Intraocular Pressure | February 17, 2023 | December 2024 |
| NCT04770324 | Active, not recruiting | N/A | Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI 2) | February 15, 2021 | March 31, 2024 |
| NCT03519386 | Active, not recruiting | Phase 3 | Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5% | July 26, 2018 | June 2024 |
| NCT04624698 | Active, not recruiting | N/A | iStent Inject New Enrollment Post-Approval Study | September 22, 2020 | May 2026 |
| NCT00334750 | Completed | Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada | November 2007 | April 2009 | |
| NCT00470964 | Completed | N/A | Titanium-Sapphire Laser Trabeculoplasty in Glaucoma: A Randomized Study Comparing Titanium-Sapphire With Argon Laser Trabeculoplasty in Open-Angle Glaucoma Patients | ||
| NCT00487214 | Completed | Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma | June 2002 | February 2003 | |
| NCT00570726 | Completed | Phase 1 | Treatment of Failing Blebs With Ranibizumab | June 2000 | November 2007 |
| NCT00647101 | Completed | Phase 4 | A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma | December 2003 | February 2005 |
| NCT00693485 | Completed | Phase 2 | Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy | September 2008 | August 2011 |
| NCT00707226 | Completed | Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes | November 2000 | December 2001 | |
| NCT00753168 | Completed | Phase 1/Phase 2 | Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma | September 2008 | December 2008 |
| NCT00781300 | Completed | Phase 4 | Intraocular Pressure With Loteprednol and Dexamethasone | March 2006 | February 2007 |
| NCT00801437 | Completed | Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy. | October 2008 | June 2009 | |
| NCT00824720 | Completed | Phase 2 | Safety and Efficacy of a Glaucoma Drug Delivery System | December 2008 | April 2009 |
| NCT00911924 | Completed | Phase 4 | A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma | May 2009 | September 2013 |
| NCT00913029 | Completed | Phase 4 | Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG) | May 2009 | September 2012 |
| NCT00934089 | Completed | Phase 2 | A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 | January 2010 | June 2010 |
| NCT00981422 | Completed | Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of Progression | June 2007 | June 2008 | |
| NCT00991822 | Completed | Phase 2/Phase 3 | A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle Glaucoma | May 1999 | December 2003 |
| NCT01001195 | Completed | Phase 2 | Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution | November 2009 | April 2010 |
| NCT01215786 | Completed | Phase 1 | Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma | October 2010 | December 2010 |
| NCT01217606 | Completed | Phase 3 | Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension | January 2011 | June 2015 |
| NCT01241240 | Completed | Phase 3 | Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension | March 2011 | September 2013 |
| NCT01243567 | Completed | Phase 4 | Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated | June 1, 2010 | February 14, 2012 |
| NCT01253902 | Completed | Phase 4 | Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension | December 2010 | October 2011 |
| NCT01291108 | Completed | Phase 2 | Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension | April 2011 | October 2011 |
| NCT01489670 | Completed | Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension | September 2011 | March 2013 | |
| NCT01540370 | Completed | Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT) | February 2012 | July 2012 | |
| NCT01547598 | Completed | Phase 4 | Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction | December 2011 | July 2013 |
| NCT01589510 | Completed | A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) | April 2012 | February 2013 | |
| NCT01594970 | Completed | Phase 4 | A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH) | March 2012 | January 2013 |
| NCT01628588 | Completed | Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) | March 2010 | December 2010 | |
| NCT00001152 | Completed | Pigment Dispersion Syndrome With and Without Glaucoma | June 1976 | June 2000 | |
| NCT01628614 | Completed | A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) | November 2010 | July 2011 | |
| NCT01629407 | Completed | A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years | June 2009 | May 2013 | |
| NCT01632423 | Completed | A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) | February 2010 | November 2010 | |
| NCT01637246 | Completed | A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy | April 2009 | November 2011 | |
| NCT01640756 | Completed | Phase 3 | AqueSys Microfistula Implant in Refractory Glaucoma | July 2012 | April 2015 |
| NCT01646151 | Completed | A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension | May 2012 | April 2013 | |
| NCT01735214 | Completed | An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments | March 7, 2013 | April 10, 2014 | |
| NCT01857440 | Completed | The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study | May 2013 | December 2015 | |
| NCT01976624 | Completed | Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea | August 2009 | January 2014 | |
| NCT01987752 | Completed | Safety and Efficacy of Combigan® Ophthalmic Solution in Korea | January 2009 | November 2011 | |
| NCT02003534 | Completed | Phase 4 | A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension | July 2010 | February 2013 |
| NCT02020512 | Completed | Phase 4 | A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension | July 2011 | December 2012 |
| NCT02061683 | Completed | Phase 4 | A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension | April 19, 2010 | June 24, 2011 |
| NCT02247804 | Completed | Phase 3 | Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension | December 15, 2014 | July 19, 2019 |
| NCT02250651 | Completed | Phase 3 | Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension | December 15, 2014 | July 22, 2020 |
| NCT02338362 | Completed | Phase 4 | Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma | September 2014 | February 2015 |
| NCT02376114 | Completed | Phase 2 | Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma | August 2011 | February 2014 |
| NCT02388360 | Completed | Phase 4 | The Impact of Topical Prostaglandins on the Biomechanical Properties of the Cornea in Patients With Open Angle Glaucoma | May 6, 2013 | November 16, 2016 |
| NCT02507687 | Completed | Phase 3 | Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension | August 27, 2015 | May 31, 2023 |
| NCT02571712 | Completed | Phase 4 | Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension | November 10, 2015 | June 21, 2018 |
| NCT02754570 | Completed | N/A | The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure | July 2016 | February 21, 2018 |
| NCT02863705 | Completed | Phase 4 | Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG) | July 5, 2016 | July 25, 2018 |
| NCT03106181 | Completed | N/A | A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent | February 1, 2018 | December 31, 2022 |
| NCT01628601 | Completed | GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy | May 2010 | June 2011 | |
| NCT00051142 | Completed | Phase 3 | A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) | February 2001 | June 2004 |
| NCT00051155 | Completed | Phase 3 | A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) | January 2001 | July 2004 |
| NCT00051168 | Completed | Phase 3 | A Long-term Safety Study of Once-daily Travatan | January 2006 | |
| NCT00051194 | Completed | Phase 2 | A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension | September 2002 | July 2003 |
| NCT00140062 | Completed | Phase 4 | Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. | February 2002 | April 2006 |
| NCT00150267 | Completed | Phase 3 | A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension | February 2002 | |
| NCT00159653 | Completed | Phase 3 | A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma | July 2005 | June 2007 |
| NCT00311389 | Completed | Phase 3 | A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension | January 2003 | September 2004 |
| NCT03187418 | Completed | N/A | Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma | June 19, 2017 | February 15, 2020 |
| NCT03204487 | Completed | Phase 4 | A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness | May 10, 2016 | June 30, 2017 |
| NCT03255785 | Completed | N/A | Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One iStent and One iStent Supra | May 1, 2018 | December 3, 2019 |
| NCT03267862 | Completed | Scleral Response to Intraocular Pressure (IOP) | September 17, 2014 | August 29, 2017 | |
| NCT03293992 | Completed | Phase 1 | A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension | October 10, 2017 | December 21, 2017 |
| NCT03325751 | Completed | Visual Field Defect Estimation Using Sequentially Optimized Reconstruction Strategy on Healthy and Glaucoma Subjects | June 1, 2018 | November 1, 2019 | |
| NCT03373942 | Completed | The Effect of Pseudoexfoliation on Choroidal Thickness in Open Angle Glaucoma | August 15, 2014 | August 15, 2015 | |
| NCT03452033 | Completed | Phase 1/Phase 2 | H-1337 Ophthalmic Solution Phase 1/2 | March 15, 2018 | August 15, 2018 |
| NCT03558126 | Completed | N/A | Silicone Tube for the Surgical Treatment of Glaucoma | March 1, 2013 | October 1, 2016 |
| NCT03612817 | Completed | Phase 4 | Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing | January 2017 | July 2018 |
| NCT03624361 | Completed | N/A | MINIject Glaucoma Implant in European Patients | May 23, 2018 | September 23, 2021 |
| NCT03624699 | Completed | N/A | Investigation of the iStent Inject® Devices in Open-Angle Glaucoma | April 25, 2018 | June 30, 2020 |
| NCT03657797 | Completed | Phase 2 | Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension | August 1, 2018 | August 23, 2019 |
| NCT03689088 | Completed | N/A | Sensing Contact Lens-based Device for 24-hour Monitoring of Intraocular Pressure | May 22, 2018 | September 6, 2018 |
| NCT03797469 | Completed | N/A | Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin) | April 15, 2019 | December 31, 2020 |
| NCT03800589 | Completed | N/A | Assessment of Effectiveness Ex-Press Surgery Modification | December 1, 2010 | December 1, 2017 |
| NCT03804684 | Completed | N/A | visuALL Field Analyzer (vFA) Compared to Standard Humphrey Automated Perimetry | January 8, 2019 | October 20, 2020 |
| NCT03808688 | Completed | Phase 4 | Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting | December 27, 2018 | July 26, 2019 |
| NCT03949244 | Completed | Phase 4 | Nailfold Capillary Blood Flow With Latanoprost Bunod | August 15, 2019 | October 1, 2020 |
| NCT03966560 | Completed | Phase 4 | Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma | January 2014 | April 2015 |
| NCT03996200 | Completed | N/A | MINIject in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool | July 23, 2019 | February 10, 2022 |
| NCT04024072 | Completed | Phase 3 | To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes | June 24, 2019 | April 30, 2020 |
| NCT04202562 | Completed | N/A | Efficacy and Safety of ab Interno Trabeculectomy With the Kahook Dual Blade | February 2, 2017 | November 30, 2018 |
| NCT04214847 | Completed | N/A | The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases | February 1, 2012 | July 15, 2014 |
| NCT04215575 | Completed | N/A | Baerveldt (BGI) Valve Versus Ahmed(AGV) Valve in Management of Difficult Glaucoma Cases | January 1, 2014 | December 20, 2016 |
| NCT04297930 | Completed | Treatment Outcomes of a Novel Glaucoma Tube Shunt Implant for Intraocular Pressure Control in Eyes With Refractory Glaucoma | December 1, 2017 | December 1, 2019 | |
| NCT04406467 | Completed | Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach | November 19, 2017 | August 26, 2020 | |
| NCT04430647 | Completed | N/A | Phaco-UCP Versus Phaco Alone for OAG and Cataract | March 1, 2018 | January 30, 2020 |
| NCT04452279 | Completed | N/A | Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification | May 1, 2018 | August 15, 2019 |
| NCT04460365 | Completed | N/A | European Nutrition in Glaucoma Management Trial | October 1, 2017 | September 17, 2020 |
| NCT04476810 | Completed | N/A | Long Term Outcome of Combined Phacoemulsification and Excisional Goniotomy With the Kahook Dual Blade | January 1, 2017 | January 30, 2020 |
| NCT04619654 | Completed | N/A | Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma | February 1, 2021 | June 1, 2022 |
| NCT04632329 | Completed | N/A | Negative Pressure Applied by the Equinox MPD for Severe Open Angle Glaucoma | October 28, 2020 | August 19, 2021 |
| NCT04651231 | Completed | N/A | Punch Trabeculectomy Versus Classic Trabeculectomy | January 20, 2012 | October 16, 2014 |
| NCT04872348 | Completed | An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0) | July 1, 2021 | November 2, 2023 | |
| NCT04888156 | Completed | Impact of Self-tonometry on Glaucoma Treatment Decision. | May 10, 2021 | February 1, 2022 | |
| NCT04890106 | Completed | Phase 3 | Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma | October 2, 2021 | August 11, 2022 |
| NCT04903366 | Completed | Absorption and Safety of Topical Timolol to Treat Chronic Wounds | November 21, 2017 | January 14, 2020 | |
| NCT04944290 | Completed | Phase 3 | To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes | May 28, 2021 | June 21, 2022 |
| NCT04949802 | Completed | N/A | Glaucoma Surgery Using the ViaLase Laser System | September 1, 2020 | December 16, 2021 |
| NCT05044793 | Completed | A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System | September 30, 2021 | August 21, 2023 | |
| NCT05181046 | Completed | N/A | Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients | November 6, 2021 | December 19, 2022 |
| NCT05451329 | Completed | Phase 2 | A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure | July 12, 2022 | December 22, 2022 |
| NCT06355765 | Completed | Citicoline & Antioxidants in Glaucoma | January 10, 2022 | December 10, 2022 | |
| NCT05159960 | Enrolling by invitation | N/A | Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial | January 10, 2022 | November 30, 2025 |
| NCT06240312 | Not yet recruiting | N/A | Optic Nerve Head Strain as Biomarker for Glaucoma | July 1, 2024 | January 31, 2028 |
| NCT05593354 | Not yet recruiting | MicroPulse TLT - UK Study | May 1, 2023 | December 2025 | |
| NCT04007276 | Not yet recruiting | Phase 4 | The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients | November 10, 2025 | June 1, 2035 |
| NCT05704777 | Not yet recruiting | N/A | Exercise Intervention in Primary Open-angle Glaucoma | February 1, 2023 | December 31, 2024 |
| NCT05366647 | Not yet recruiting | N/A | GATT Versus Canaloplasty (GVC) | June 1, 2022 | June 1, 2025 |
| NCT05625958 | Not yet recruiting | N/A | Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery | March 1, 2023 | June 1, 2026 |
| NCT06289491 | Not yet recruiting | N/A | Randomized Trial of Hydrus Microstent Versus Goniotomy | April 2024 | April 2029 |
| NCT05857267 | Recruiting | Phase 4 | Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety | March 7, 2023 | November 15, 2024 |
| NCT05325996 | Recruiting | N/A | Evaluating Home Testing Devices for the Management of Glaucoma | April 15, 2022 | August 31, 2025 |
| NCT05277870 | Recruiting | N/A | Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension | February 28, 2022 | June 30, 2025 |
| NCT04750447 | Recruiting | Safety and Efficacy of an Ab Interno Gelatin Stent (XEN63) With or Without Mitomycin C | November 9, 2020 | June 9, 2023 | |
| NCT05405868 | Recruiting | Phase 3 | Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial | January 18, 2024 | June 30, 2027 |
| NCT04602923 | Recruiting | N/A | Keratometric Change After XEN, Trabeculectomy and Tube Shunts | November 4, 2020 | December 2025 |
| NCT05885022 | Recruiting | N/A | Feasibility Clinical Evaluation of the Calibreye System | May 31, 2023 | April 2025 |
| NCT05949242 | Recruiting | N/A | Clinical Outcomes in Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent | April 7, 2023 | October 2024 |
| NCT06058598 | Recruiting | N/A | Exercise Training in Patients With Glaucoma | December 1, 2023 | June 30, 2027 |
| NCT05624398 | Recruiting | N/A | Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery | December 7, 2022 | June 1, 2024 |
| NCT03267849 | Recruiting | N/A | Lamina Cribrosa Depth Change With Change in Eye Pressure | July 1, 2017 | July 1, 2025 |
| NCT06066645 | Recruiting | Phase 3 | Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone | September 14, 2023 | November 2025 |
| NCT05626426 | Recruiting | N/A | Electrical Stimulation for the Treatment of Optic Neuropathies | February 27, 2023 | December 2024 |
| NCT05401357 | Recruiting | Phase 3 | Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. | June 29, 2022 | December 2022 |
| NCT06154330 | Recruiting | Safety and Efficacy of Suprachoroidal Tube Shunt in Patients With Primary Open and Pseudoexfoliation Glaucomas | November 20, 2023 | December 23, 2023 | |
| NCT02959242 | Recruiting | Dresden Glaucoma and Treatment Study (DGTS) | January 2006 | December 2026 | |
| NCT06201455 | Recruiting | N/A | Evaluation of Phacogoniotomy in Medically-controlled POAG | September 28, 2023 | December 31, 2029 |
| NCT05039684 | Recruiting | Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical Prostaglandins | October 1, 2021 | December 2023 | |
| NCT06369077 | Recruiting | Phase 4 | How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure? | April 2024 | July 2024 |
| NCT05626491 | Recruiting | N/A | Electrical Stimulation for the Treatment of Glaucoma | February 28, 2023 | December 2024 |
| NCT05710198 | Recruiting | Phase 3 | Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma | December 11, 2023 | April 1, 2027 |
| NCT03736655 | Terminated | N/A | Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma | March 15, 2019 | October 25, 2021 |
| NCT04658095 | Terminated | N/A | Study of OMNI Surgical System and iStent for Eyes With OAG (Trident) | December 14, 2021 | August 9, 2022 |
| NCT04702789 | Terminated | Phase 4 | Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. | October 19, 2021 | November 23, 2023 |
| NCT03875911 | Terminated | Phase 4 | Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy | March 30, 2019 | December 31, 2022 |
| NCT01416415 | Terminated | N/A | Glaucoma Eye Drop Instillation: Impact of Education | August 2011 | June 2013 |
| NCT03255798 | Terminated | N/A | A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra | August 1, 2017 | June 6, 2019 |
| NCT04616573 | Terminated | N/A | A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma | November 13, 2020 | January 20, 2021 |
| NCT04465630 | Terminated | N/A | A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma | June 19, 2020 | March 2, 2021 |
| NCT03445806 | Terminated | IOP Monitoring After Trabeculectomy Using iCare Home | February 26, 2018 | March 22, 2021 | |
| NCT03634319 | Terminated | N/A | Early Evaluation of the Beacon Aqueous Microshunt in Patients Refractory to Drug Therapy in the European Union | June 1, 2018 | January 8, 2023 |
| NCT00410267 | Terminated | Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & Cells | February 2006 | December 2007 | |
| NCT04038034 | Unknown status | N/A | Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma | September 1, 2019 | August 30, 2021 |
| NCT04624685 | Unknown status | iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study | January 15, 2020 | December 2021 | |
| NCT01430923 | Unknown status | N/A | Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost | September 2011 | August 2012 |
| NCT04703959 | Unknown status | Glaucoma and Sleep Quality | January 2021 | January 2022 | |
| NCT03151577 | Unknown status | N/A | Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent | January 1, 2015 | May 31, 2023 |
| NCT04900142 | Unknown status | N/A | Micropulsed Laser Trabeculoplasty Using Different Parameters | March 20, 2020 | June 20, 2022 |
| NCT04912362 | Unknown status | N/A | The Effectiveness of YAG Iridotomy in Preventing Peripheral Anterior Synechia After CLASS in Primary Open Angle Glaucoma | September 1, 2020 | August 2023 |
| NCT03369886 | Unknown status | N/A | The Relationship Between Macular OCTA and GCIPL and Their Combinational Index Using AI | September 25, 2017 | August 31, 2018 |
| NCT04920227 | Unknown status | N/A | Comparation of CLASS Combined With Phacoemulsification and CLASS Alone in the Treatment of Primary Open Angle Glaucoma | September 2, 2020 | August 2023 |
| NCT01254058 | Unknown status | Saccadic Eye Movements Are Impaired In Glaucoma | July 2010 | April 2020 | |
| NCT05130554 | Unknown status | N/A | XEN45 in the Treatment of Chinese Patients With Primary Open-angle Glaucoma | November 7, 2021 | September 30, 2022 |
| NCT02679482 | Unknown status | Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma | September 2014 | October 2016 | |
| NCT02379208 | Unknown status | Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma | April 2015 | May 2020 | |
| NCT03870230 | Unknown status | N/A | Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects | December 1, 2017 | March 2023 |
| NCT05299593 | Unknown status | Phase 4 | 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration. | June 4, 2020 | June 30, 2022 |
| NCT04234932 | Unknown status | Early Phase 1 | Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation | January 6, 2020 | January 2021 |
| NCT05043831 | Withdrawn | N/A | Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population The Zhuiguang Trial | October 15, 2021 | April 15, 2023 |
| NCT04676126 | Withdrawn | Phase 4 | Augmented Macular Pigment-containing Nutraceutical and Central Visual Function | May 2021 | May 2022 |
| NCT00143429 | Withdrawn | Phase 2 | Corneal Versus Conjunctival Delivery Using a Delivery Device | ||
| NCT03274323 | Withdrawn | N/A | Trabeculectomy Versus 2-iStent and Prostaglandin Study | January 12, 2018 | January 12, 2018 |
| NCT00283764 | Withdrawn | Phase 3 | Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D005902